Growth Metrics

Accuray (ARAY) Equity Income (2020 - 2026)

Accuray posted quarterly Equity Income of $408000.0 for Q1 2026, down 82.24% year-on-year from $2.3 million in Q1 2025, and down 13.38% on a QoQ basis from $471000.0 in Q4 2025.

Accuray (ARAY) has 7 years of Equity Income data on file, last reported at $408000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Income fell 82.24% year-over-year to $408000.0; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 25.51% YoY), and the FY2025 full-year result was $4.7 million, up 156.47% from the prior year.
  • Equity Income for Q1 2026 stood at $408000.0, down from $471000.0 in the prior quarter.
  • Across five years, Equity Income topped out at $2.3 million in Q1 2025 and bottomed at -$699000.0 in Q4 2022.
  • The 5-year median for Equity Income is $439000.0 (2025), against an average of $698538.5.
  • The widest annual swing landed in 2022, when Equity Income surged 2961.76%; it then sank 116.71% in 2024.
  • A 5-year view of Equity Income shows it stood at -$699000.0 in 2022, then surged by 38.91% to -$427000.0 in 2023, then soared by 475.64% to $1.6 million in 2024, then tumbled by 70.64% to $471000.0 in 2025, then fell by 13.38% to $408000.0 in 2026.
  • The last three Equity Income figures came in at $408000.0 (Q1 2026), $471000.0 (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Accuray 47,295.88 -38.49 Mn 25.29 Mn 408,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 408,000.00
Dec 31, 2025 471,000.00
Sep 30, 2025 439,000.00
Mar 31, 2025 2.30 Mn
Dec 31, 2024 1.60 Mn
Sep 30, 2024 -72,000.00
Mar 31, 2024 1.02 Mn
Dec 31, 2023 -427,000.00
Sep 30, 2023 431,000.00
Mar 31, 2023 2.03 Mn
Dec 31, 2022 -699,000.00
Sep 30, 2022 -368,000.00
Mar 31, 2022 1.95 Mn
Dec 31, 2021 -832,000.00
Sep 30, 2021 -340,000.00
Mar 31, 2021 -68,000.00
Dec 31, 2020 1.12 Mn